Vigil Neuro
Hannah Tucker is a professional with experience in regulatory affairs, clinical trials, and clinical research coordination. Hannah currently holds the position of Senior Regulatory Affairs Associate at Vigil Neuroscience. Prior to this, Hannah worked at Adams Clinical as a Senior Clinical Research Coordinator. Hannah Tucker obtained their Bachelor of Science in Human Development from Cornell University.
This person is not in any offices
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.